Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding

@article{Odagaki2005TrazodoneAI,
  title={Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding},
  author={Y. Odagaki and R. Toyoshima and T. Yamauchi},
  journal={Journal of Psychopharmacology},
  year={2005},
  volume={19},
  pages={235 - 241}
}
  • Y. Odagaki, R. Toyoshima, T. Yamauchi
  • Published 2005
  • Chemistry, Medicine
  • Journal of Psychopharmacology
    • Trazodone is an effective antidepressant drug with a broad therapeutic spectrum, including anxiolytic efficacy. Although trazodone is usually referred to as a serotonin (5-HT) reuptake inhibitor, this pharmacological effect appears to be too weak to fully account for its clinical effectiveness. The present study aimed to elucidate the agonist properties of trazodone and its active metabolite, m-chlorophenylpiperazine (m-CPP), at 5-HT1A receptors by means of the guanosine-5′-O-(3-[35S]thio… CONTINUE READING
    View on SAGE
    ncbi.nlm.nih.gov
    42 Citations
    Highly Influencial Citations
    2
    Background Citations
    11
    Results Citations
    1
    42 Citations
    Citation Type

    Citation Type

    Sustained Administration of Trazodone Enhances Serotonergic Neurotransmission: In Vivo Electrophysiological Study in the Rat Brain
    • 26
    • PDF
    Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism
    • 2
    Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics.
    • W. Shi, Yu Wang, +7 authors J. Shen
    • Chemistry, Medicine
    • Bioorganic & medicinal chemistry letters
    • 2020
    Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m‐chlorophenylpiperazine in the horse
    • 4
    Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature
    • 25
    • PDF
    Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
    • 28
    Evaluating the dose-dependent mechanism of action of trazodone by estimation of occupancies for different brain neurotransmitter targets
    • 9
    • PDF
    5-HT1A receptor-mediated G protein activation assessed by [35S]GTPγS binding in rat cerebral cortex
    • 14
    Rediscovering Trazodone for the Treatment of Major Depressive Disorder
    • 95
    • PDF
    Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain
    • 26

    References

    SHOWING 1-10 OF 50 REFERENCES
    Biochemical investigations into the mode of action of trazodone
    • 62
    Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study
    • 198
    • Highly Influential
    The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.
    • 323
    Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons
    • 36
    • Highly Influential
    Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum.
    • 35
    • PDF
    Interactions of trazodone with serotonin neurons and receptors
    • 47
    A comparison of trazodone and fluoxetine: implications for a serotonergic mechanis of antidepressant action
    • 53
    5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    • 53
    Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes
    • 19
    BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex
    • 33
    • Highly Influential